Hy2care

Hy2care

Hy2Care develops the CartRevive Hydrogel implant for treating traumatic cartilage defects, enabling natural healing of the cartilage.

HQ location
Geleen, Netherlands
Website
hy2care.com
Launch date
Employees
11-50 people
Enterprise value
$20—30m
Company register number
62035274
https://twitter.com/hy2carehttps://www.linkedin.com/company/hy2care-bv/
    • Edit
loading funding rounds…
European Innovation Council
European Innovation Council
Brightlands Venture Partners
Brightlands Venture Partners
Rainmaking
Rainmaking
LifeSciences@work
LifeSciences@work
Startupbootcamp
Startupbootcamp
LIOF - Limburg Regional Development Agency
LIOF - Limburg Regional Development Agency
EIC Fund
EIC Fund
University of Twente
University of Twente

Related Content

More about Hy2care
Edit

Revolutionizing cartilage recovery: Hy2Care’s CartRevive hydrogel implant realizes optimal repair of cartilage defects. After sports mishaps, slips, or falls, our patented hydrogel offers a scaffold of joint-matching composition, guiding natural cell growth and enabling the body to heal itself. Currently under clinical examination in the Netherlands for EU approval, with US trials coming up. Dive into the future of joint repair with us!

Keywords: Arthroscopic Treatment, Cartilage Defect Functional Repair, Cartilage Repair, Hydrogel implant, Knee Injury, Joint Preservation.

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo